{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:01:27Z","timestamp":1791892887399,"version":"4.3.4"},"reference-count":99,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"unspecified","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA285585"],"award-info":[{"award-number":["R01CA285585"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["R01DE033473"],"award-info":[{"award-number":["R01DE033473"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2026,9,30]]},"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1136\/jitc-2026-016157","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:15:27Z","timestamp":1791890127000},"page":"e016157","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Sensory innervation shapes cancer immunotherapy efficacy and adverse events"],"prefix":"10.1136","volume":"14","clinical-trial-number":[{"clinical-trial-number":"nct03013218","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02907099","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03010176","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02740270","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03707093","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct06530524","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01822210","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01520441","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02522611","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03226574","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00804154","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02977195","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05605496","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct06203821","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03565445","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04094506","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Natalie S","family":"Adamczyk","sequence":"first","affiliation":[{"name":"Neurobiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jami L","family":"Saloman","sequence":"additional","affiliation":[{"name":"Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5587-4990","authenticated-orcid":false,"given":"Nicole N","family":"Scheff","sequence":"additional","affiliation":[{"name":"Neurobiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,10,13]]},"reference":[{"key":"2026101304152291000_14.10.e016157.1","doi-asserted-by":"crossref","first-page":"106239","DOI":"10.1016\/j.bbi.2025.106239","article-title":"Neural control of Immunotherapy: how Tumor-innervation shapes Anti-Tumor immune responses","volume":"132","author":"Satilmis","year":"2026","journal-title":"Brain Behav Immun"},{"key":"2026101304152291000_14.10.e016157.2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.trecan.2025.01.003","article-title":"Sensory neurotransmission and pain in solid tumor progression","volume":"11","author":"Martel Matos","year":"2025","journal-title":"Trends Cancer"},{"key":"2026101304152291000_14.10.e016157.3","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.trecan.2025.07.004","article-title":"CGRP-mediated neural addiction in tumor dynamic remodeling","volume":"11","author":"Xu","year":"2025","journal-title":"Trends Cancer"},{"key":"2026101304152291000_14.10.e016157.4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01440"},{"key":"2026101304152291000_14.10.e016157.5","doi-asserted-by":"crossref","DOI":"10.1007\/s10555-025-10241-x","article-title":"Sympathetic nerve signaling rewires the tumor microenvironment: a shift in \u201cmicroenvironmental-ity\u201d","volume":"44","author":"Sattler","year":"2025","journal-title":"Cancer Metastasis Rev"},{"key":"2026101304152291000_14.10.e016157.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.09.028"},{"key":"2026101304152291000_14.10.e016157.7","doi-asserted-by":"publisher","DOI":"10.1038\/35093019"},{"key":"2026101304152291000_14.10.e016157.8","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-025-00831-w"},{"key":"2026101304152291000_14.10.e016157.9","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-025-10249-3"},{"key":"2026101304152291000_14.10.e016157.10","doi-asserted-by":"crossref","first-page":"116928","DOI":"10.1016\/j.celrep.2026.116928","article-title":"Oncogenic influences of neurotrophin receptors: Shedding light on Trk biology","volume":"45","author":"Jagana","year":"2026","journal-title":"Cell Rep"},{"key":"2026101304152291000_14.10.e016157.11","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-025-02336-4","article-title":"Cancer-nervous system crosstalk: from biological mechanism to therapeutic opportunities","volume":"24","author":"Huang","year":"2025","journal-title":"Mol Cancer"},{"key":"2026101304152291000_14.10.e016157.12","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-2793"},{"key":"2026101304152291000_14.10.e016157.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2025.07.017"},{"key":"2026101304152291000_14.10.e016157.14","doi-asserted-by":"publisher","DOI":"10.3390\/molecules200610657"},{"key":"2026101304152291000_14.10.e016157.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2011.07.020"},{"key":"2026101304152291000_14.10.e016157.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2005.02.022"},{"key":"2026101304152291000_14.10.e016157.17","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3390\/cimb46020062","article-title":"Nerve Growth Factor and the Role of Inflammation in Tumor Development","volume":"46","author":"Ferraguti","year":"2024","journal-title":"CIMB"},{"key":"2026101304152291000_14.10.e016157.18","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002382"},{"key":"2026101304152291000_14.10.e016157.19","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(94)90323-9"},{"key":"2026101304152291000_14.10.e016157.20","doi-asserted-by":"crossref","first-page":"105409","DOI":"10.1016\/j.jpain.2025.105409","article-title":"Truncated TrkB: The predominant TrkB isoform in nociceptors","volume":"31","author":"Merlo","year":"2025","journal-title":"J Pain"},{"key":"2026101304152291000_14.10.e016157.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2005.05.002"},{"key":"2026101304152291000_14.10.e016157.22","doi-asserted-by":"publisher","DOI":"10.1016\/S1050-1738(01)00140-2"},{"key":"2026101304152291000_14.10.e016157.23","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0404-23.2023"},{"key":"2026101304152291000_14.10.e016157.24","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07767-5"},{"key":"2026101304152291000_14.10.e016157.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2005.01.013"},{"key":"2026101304152291000_14.10.e016157.26","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.05.065"},{"key":"2026101304152291000_14.10.e016157.27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41523-022-00485-z","article-title":"Sensory nerves enhance triple-negative breast cancer invasion and metastasis via the axon guidance molecule PlexinB3","volume":"8","author":"Le","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"2026101304152291000_14.10.e016157.28","doi-asserted-by":"crossref","unstructured":"McIlvried LA , Gelboin-Burkhart CA , Scheff NN . Neural architecture as cancer\u2019s safe harbor. Sci Transl Med 2026;18. doi:10.1126\/scitranslmed.aeg3160","DOI":"10.1126\/scitranslmed.aeg3160"},{"key":"2026101304152291000_14.10.e016157.29","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601751"},{"key":"2026101304152291000_14.10.e016157.30","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-12-0609"},{"key":"2026101304152291000_14.10.e016157.31","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade4443","article-title":"Functional neuronal circuits promote disease progression in cancer","volume":"9","author":"Restaino","year":"2023","journal-title":"Sci Adv"},{"key":"2026101304152291000_14.10.e016157.32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s13193-020-01210-7","article-title":"Neuropeptide Substance P Enhances Inflammation-Mediated Tumor Signaling Pathways and Migration and Proliferation of Head and Neck Cancers","volume":"12","author":"Singh","year":"2021","journal-title":"Indian J Surg Oncol"},{"key":"2026101304152291000_14.10.e016157.33","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1007\/s00018-016-2293-z","article-title":"Neuropeptide substance P and the immune response","volume":"73","author":"Mashaghi","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"2026101304152291000_14.10.e016157.34","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.ccell.2025.09.003","article-title":"Sensory neurons drive pancreatic cancer progression through glutamatergic neuron-cancer pseudo-synapses","volume":"43","author":"Ren","year":"2025","journal-title":"Cancer Cell"},{"key":"2026101304152291000_14.10.e016157.35","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/s41586-025-09434-9","article-title":"Functional synapses between neurons and small cell lung cancer","volume":"646","author":"Sakthivelu","year":"2025","journal-title":"Nature"},{"key":"2026101304152291000_14.10.e016157.36","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-60922-y","article-title":"Metabotropic glutamate receptor 4-mediated glutamatfergic signaling reshapes the tumor microenvironment by regulating dendritic cell maturation","volume":"16","author":"Ju","year":"2025","journal-title":"Nat Commun"},{"key":"2026101304152291000_14.10.e016157.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2022.09.001"},{"key":"2026101304152291000_14.10.e016157.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108476"},{"key":"2026101304152291000_14.10.e016157.39","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000967","article-title":"Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy","volume":"8","author":"Chuckran","year":"2020","journal-title":"J Immunother Cancer"},{"key":"2026101304152291000_14.10.e016157.40","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-06-2445"},{"key":"2026101304152291000_14.10.e016157.41","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1002\/ijc.22949","article-title":"Association of axon guidance factor Semaphorin 3A with poor outcome in pancreatic cancer","volume":"121","author":"M\u00fcller","year":"2007","journal-title":"Intl Journal of Cancer"},{"key":"2026101304152291000_14.10.e016157.42","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4571"},{"key":"2026101304152291000_14.10.e016157.43","doi-asserted-by":"crossref","unstructured":"Liu BL , Cao QL , Zhao X , et al . Inhibition of TRPV1 by SHP-1 in nociceptive primary sensory neurons is critical in PD-L1 analgesia. JCI Insight 2020;5. doi:10.1172\/jci.insight.137386","DOI":"10.1172\/jci.insight.137386"},{"key":"2026101304152291000_14.10.e016157.44","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1002\/ijc.32061","article-title":"Expression of PD\u2010L1 in tumor\u2010associated nerves correlates with reduced CD8 + tumor\u2010associated lymphocytes and poor prognosis in prostate cancer","volume":"144","author":"Mo","year":"2019","journal-title":"Intl Journal of Cancer"},{"key":"2026101304152291000_14.10.e016157.45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218159","article-title":"Delicate Role of PD-L1\/PD-1 Axis in Blood Vessel Inflammatory Diseases: Current Insight and Future Significance","volume":"21","author":"Veluswamy","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026101304152291000_14.10.e016157.46","doi-asserted-by":"crossref","first-page":"6754","DOI":"10.1016\/j.cell.2025.09.029","article-title":"Cancer cells co-opt an inter-organ neuroimmune circuit to escape immune surveillance","volume":"188","author":"Zhang","year":"2025","journal-title":"Cell"},{"key":"2026101304152291000_14.10.e016157.47","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-0899"},{"key":"2026101304152291000_14.10.e016157.48","doi-asserted-by":"publisher","DOI":"10.1016\/J.CELL.2026.01.001"},{"key":"2026101304152291000_14.10.e016157.49","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.it.2024.12.006","article-title":"Immune evasion in ovarian cancer: implications for immunotherapy and emerging treatments","volume":"46","author":"Gupta","year":"2025","journal-title":"Trends Immunol"},{"key":"2026101304152291000_14.10.e016157.50","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-024-00868-0"},{"key":"2026101304152291000_14.10.e016157.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2015.04.017"},{"key":"2026101304152291000_14.10.e016157.52","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s40265-020-01327-7","article-title":"Immunomodulatory Roles of VEGF Pathway Inhibitors in Renal Cell Carcinoma","volume":"80","author":"Hirsch","year":"2020","journal-title":"Drugs"},{"key":"2026101304152291000_14.10.e016157.53","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920907504","article-title":"Tyrosine kinase inhibitors and immunotherapy combinations in renal cell carcinoma","volume":"12","author":"Rassy","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"2026101304152291000_14.10.e016157.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.04.024"},{"key":"2026101304152291000_14.10.e016157.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.11.007"},{"key":"2026101304152291000_14.10.e016157.56","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-1183"},{"key":"2026101304152291000_14.10.e016157.57","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/MPA.0000000000001090","article-title":"Systemic Depletion of Nerve Growth Factor Inhibits Disease Progression in a Genetically Engineered Model of Pancreatic Ductal Adenocarcinoma","volume":"47","author":"Saloman","year":"2018","journal-title":"Pancreas"},{"key":"2026101304152291000_14.10.e016157.58","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01723-7"},{"key":"2026101304152291000_14.10.e016157.59","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.immuni.2025.11.021","article-title":"Immune signature-based uncoupling of checkpoint inhibitor efficacy and toxicity","volume":"59","author":"Lucas","year":"2026","journal-title":"Immunity"},{"key":"2026101304152291000_14.10.e016157.60","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/ijc.70414","article-title":"Systemic anti-cancer therapy associated with the occurrence of peripheral neurotoxicity and, specifically, peripheral neuropathy","volume":"159","author":"Higgins","year":"2026","journal-title":"Int J Cancer"},{"key":"2026101304152291000_14.10.e016157.61","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3946"},{"key":"2026101304152291000_14.10.e016157.62","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00035.2017"},{"key":"2026101304152291000_14.10.e016157.63","doi-asserted-by":"crossref","first-page":"e1093","DOI":"10.1212\/WNL.0000000000008091","article-title":"Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies","volume":"93","author":"Dubey","year":"2019","journal-title":"Neurology"},{"key":"2026101304152291000_14.10.e016157.64","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1007\/s00415-023-11625-1","article-title":"Peripheral nervous system adverse events associated with immune checkpoint inhibitors","volume":"270","author":"Rossi","year":"2023","journal-title":"J Neurol"},{"key":"2026101304152291000_14.10.e016157.65","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2020-1222"},{"key":"2026101304152291000_14.10.e016157.66","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/TCRM.S479686","article-title":"Risk of Serious Immune-Related Adverse Events with Various PD1 and PD-L1 Inhibitors: A Single-Institution, Real-Life, Comparative Study","volume":"21","author":"Boucheron","year":"2025","journal-title":"Ther Clin Risk Manag"},{"key":"2026101304152291000_14.10.e016157.67","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1158\/2326-6066.CIR-22-0003","article-title":"PD-1\/PD-L1 Inhibition Enhances Chemotherapy-Induced Neuropathic Pain by Suppressing Neuroimmune Antinociceptive Signaling","volume":"10","author":"Wanderley","year":"2022","journal-title":"Cancer Immunol Res"},{"key":"2026101304152291000_14.10.e016157.68","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2024.03.008"},{"key":"2026101304152291000_14.10.e016157.69","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.mucimm.2024.10.001","article-title":"Sensory neuroimmune interactions at the barrier","volume":"17","author":"Wang","year":"2024","journal-title":"Mucosal Immunol"},{"key":"2026101304152291000_14.10.e016157.70","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.it.2024.03.008","article-title":"Sensory neuronal control of skin barrier immunity","volume":"45","author":"Feng","year":"2024","journal-title":"Trends Immunol"},{"key":"2026101304152291000_14.10.e016157.71","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-025-03626-w","article-title":"IL-2\/IL-2R\u03b2\u03b3 signaling in pruriceptors drives neuroimmune mechanisms of nivolumab-induced persistent itch","volume":"22","author":"Li","year":"2025","journal-title":"J Neuroinflammation"},{"key":"2026101304152291000_14.10.e016157.72","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.02.002"},{"key":"2026101304152291000_14.10.e016157.73","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102091","article-title":"Neural signaling modulates metabolism of gastric cancer","volume":"24","author":"Rabben","year":"2021","journal-title":"iScience"},{"key":"2026101304152291000_14.10.e016157.74","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/463574","article-title":"Botulinum neurotoxin type A for the treatment of benign prostatic hyperplasia: randomized study comparing two doses","volume":"2012","author":"Arnouk","year":"2012","journal-title":"ScientificWorldJournal"},{"key":"2026101304152291000_14.10.e016157.75","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.juro.2011.04.062","article-title":"Effects of 100 and 300 Units of Onabotulinum Toxin A on Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Phase II Randomized Clinical Trial","volume":"186","author":"Crawford","year":"2011","journal-title":"Journal of Urology"},{"key":"2026101304152291000_14.10.e016157.76","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07237-y"},{"key":"2026101304152291000_14.10.e016157.77","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1093\/jnci\/djaf178","article-title":"Aprepitant use during chemotherapy and association with survival in women with early breast cancer","volume":"117","author":"Botteri","year":"2025","journal-title":"J Natl Cancer Inst"},{"key":"2026101304152291000_14.10.e016157.78","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06367-z"},{"key":"2026101304152291000_14.10.e016157.79","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-023-01209-x"},{"key":"2026101304152291000_14.10.e016157.80","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113369"},{"key":"2026101304152291000_14.10.e016157.81","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.12.061"},{"key":"2026101304152291000_14.10.e016157.82","doi-asserted-by":"publisher","DOI":"10.4161\/cc.9.7.11072"},{"key":"2026101304152291000_14.10.e016157.83","doi-asserted-by":"crossref","first-page":"213881","DOI":"10.1016\/j.bioadv.2024.213881","article-title":"Anti-Netrin-1 decorated nanoparticles combined with chemotherapy for the treatment of triple-negative breast cancer","volume":"161","author":"Breusa","year":"2024","journal-title":"Biomater Adv"},{"key":"2026101304152291000_14.10.e016157.84","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-014-2426-8"},{"key":"2026101304152291000_14.10.e016157.85","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-014-0071-z"},{"key":"2026101304152291000_14.10.e016157.86","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-021-08998-9","article-title":"The neuropeptide calcitonin gene-related peptide links perineural invasion with lymph node metastasis in oral squamous cell carcinoma","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Cancer"},{"key":"2026101304152291000_14.10.e016157.87","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009910","article-title":"CAR T cells secreting NGF-neutralizing scFv enhance efficacy in clear cell renal cell carcinoma by relieving immunosuppression through immunosympathectomy","volume":"12","author":"Yang","year":"2024","journal-title":"J Immunother Cancer"},{"key":"2026101304152291000_14.10.e016157.88","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011609","article-title":"Targeting nerve growth factor: an Achilles\u2019 heel for tumors?","volume":"13","author":"Repasky","year":"2025","journal-title":"J Immunother Cancer"},{"key":"2026101304152291000_14.10.e016157.89","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40478-025-01965-6","article-title":"Development of CAR-T cell therapy for NF1\/SWN-related nerve sheath tumor treatment","volume":"13","author":"Tang","year":"2025","journal-title":"acta neuropathol commun"},{"key":"2026101304152291000_14.10.e016157.90","doi-asserted-by":"crossref","unstructured":"Mao X , Ou MT , Karuppagounder SS , et al . Pathological \u03b1-synuclein transmission initiated by binding lymphocyte-activation gene 3. Science 2016;353. doi:10.1126\/science.aah3374","DOI":"10.1126\/science.aah3374"},{"key":"2026101304152291000_14.10.e016157.91","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1976"},{"key":"2026101304152291000_14.10.e016157.92","doi-asserted-by":"publisher","DOI":"10.1172\/JCI45414"},{"key":"2026101304152291000_14.10.e016157.93","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01857-2"},{"key":"2026101304152291000_14.10.e016157.94","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3881"},{"key":"2026101304152291000_14.10.e016157.95","doi-asserted-by":"crossref","first-page":"102405","DOI":"10.1016\/j.pneurobio.2023.102405","article-title":"Activation of neuronal FLT3 promotes exaggerated sensorial and emotional pain-related behaviors facilitating the transition from acute to chronic pain","volume":"222","author":"Tassou","year":"2023","journal-title":"Prog Neurobiol"},{"key":"2026101304152291000_14.10.e016157.96","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1744-8069-10-42","article-title":"CXCR4 Chemokine Receptor Signaling Mediates Pain in Diabetic Neuropathy","volume":"10","author":"Menichella","year":"2014","journal-title":"Mol Pain"},{"key":"2026101304152291000_14.10.e016157.97","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-03151-1"},{"key":"2026101304152291000_14.10.e016157.98","doi-asserted-by":"publisher","DOI":"10.1038\/nn2034"},{"key":"2026101304152291000_14.10.e016157.99","doi-asserted-by":"crossref","first-page":"117269","DOI":"10.1016\/j.celrep.2026.117269","article-title":"Lymphotoxin-beta receptor controls the development of chronic pain","volume":"45","author":"Tumanov","year":"2026","journal-title":"Cell Rep"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2026-016157","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:15:34Z","timestamp":1791890134000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2026-016157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":99,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,13]]},"published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1136\/jitc-2026-016157"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2026-016157","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]}}}